Literature DB >> 28712044

Is it time to revise linezolid dose in elderly patients?

Marco Tinelli1, Cristina Gervasoni2, Manuela Piazza1, Roberta Terzi2, Valeria Cozzi3, Elena Maffezzini1, Chiara Cerri1, Simone Castoldi3, Sara Baldelli3, Dario Cattaneo4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28712044     DOI： 10.1007/s00228-017-2303-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

Review 1.  Pharmacokinetics and drug metabolism in the elderly.

Authors:  Ulrich Klotz
Journal:  Drug Metab Rev       Date:  2009       Impact factor: 4.518

2.  Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.

Authors:  Kazuaki Matsumoto; Akari Shigemi; Ayumi Takeshita; Erika Watanabe; Yuta Yokoyama; Kazuro Ikawa; Norifumi Morikawa; Yasuo Takeda
Journal:  Int J Antimicrob Agents       Date:  2014-06-24       Impact factor: 5.283

3.  Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis.

Authors:  Federico Pea; Mario Furlanut; Piergiorgio Cojutti; Francesco Cristini; Eleonora Zamparini; Loretta Franceschi; Pierluigi Viale
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

Review 4.  Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.

Authors:  Dario Cattaneo; Jan-Willem Alffenaar; Michael Neely
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-03-28       Impact factor: 4.481

5.  Therapeutic drug management of linezolid: a missed opportunity for clinicians?

Authors:  Dario Cattaneo; Cristina Gervasoni; Valeria Cozzi; Simone Castoldi; Sara Baldelli; Emilio Clementi
Journal:  Int J Antimicrob Agents       Date:  2016-10-12       Impact factor: 5.283

6.  Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals.

Authors:  Nibu Parameswaran Nair; Leanne Chalmers; Bonnie J Bereznicki; Colin Curtain; Gregory M Peterson; Michael Connolly; Luke R Bereznicki
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

7.  Is inappropriate medication use a major cause of adverse drug reactions in the elderly?

Authors:  Marie-Laure Laroche; Jean-Pierre Charmes; Yves Nouaille; Nicolas Picard; Louis Merle
Journal:  Br J Clin Pharmacol       Date:  2006-12-07       Impact factor: 4.335

8.  Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey.

Authors:  Pascale Olivier; Lionel Bertrand; Marie Tubery; Dominique Lauque; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections.

Authors:  Dario Cattaneo; Giovanna Orlando; Valeria Cozzi; Laura Cordier; Sara Baldelli; Stefania Merli; Serena Fucile; Cecilia Gulisano; Giuliano Rizzardini; Emilio Clementi
Journal:  Int J Antimicrob Agents       Date:  2013-04-04       Impact factor: 5.283

10.  Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients.

Authors:  Sadahiro Abe; Koji Chiba; Brenda Cirincione; Thaddeus H Grasela; Kaori Ito; Toshio Suwa
Journal:  J Clin Pharmacol       Date:  2009-06-23       Impact factor: 3.126
  10 in total
  1 in total

Review 1.  A Review of Population Pharmacokinetic Analyses of Linezolid.

Authors:  Enrique Bandín-Vilar; Laura García-Quintanilla; Ana Castro-Balado; Irene Zarra-Ferro; Miguel González-Barcia; Manuel Campos-Toimil; Víctor Mangas-Sanjuan; Cristina Mondelo-García; Anxo Fernández-Ferreiro
Journal:  Clin Pharmacokinet       Date:  2022-06-14       Impact factor: 5.577
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.